Regulation of Vasopressin Secretion
加压素分泌的调节
基本信息
- 批准号:7883281
- 负责人:
- 金额:$ 37.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AMPA ReceptorsAdenosineAdrenergic ReceptorAfferent PathwaysAmericanArousalBindingBlood VolumeBrain StemCellsChemosensitizationComplexCouplingCyclic AMP-Dependent Protein KinasesDataEvaluationExposure toFigs - dietaryFundingGene ExpressionGenetic TranscriptionGoalsGrantHeartHemorrhageHormonesHourHypothalamic structureImaging TechniquesLifeLobeMAP Kinase GeneMediatingMetabolismNeuronsNeurotransmittersNorepinephrineOsmolalitiesP2X-receptorPatternPhenylephrineProtein Kinase CProteinsPublicationsPurinoceptorRegulationRoleSignal TransductionSignaling MoleculeSystemTestingVasopressinsWorkdesensitizationpressurepreventreceptorreceptor couplingrelating to nervous systemresearch studyresponserhosupraoptic nucleussynergism
项目摘要
Two years of support for this project will allow us to perform the experiments proposed in Aims 3 and 4 of the original application. We have been able to complete the bulk of Aims 1 and 2 with support from the American Heart Assoc. This supported our hypothesis that simultaneous exposure of supraoptic neurons (SON) to ATP and phenylephrine induces a shift to non-desensitizing ionotropic purinergic receptor subtypes that allow ATP to sustain vasopressin (VP) release for hours. This work has been submitted for publication. The AHA grant does not provide support for Aims 3 and 4 which are crucial to understanding the mechanism by which norepinephrine can induce the shift in purinergic receptor subtype: Aim 3 is focused on identifying the 1-adrenergic receptor subtype activated by phenylephrine in SON and Aim 4 will identify the signal cascades activated by phenylephrine in SON. Identifying the 1-R signal cascade is critical to understanding why ATP activation of metabotropic purinergic receptors does not induce the same effect as phenylephrine. The ability of phenylephrine to induce sustained responses to ATP is important, because it provides a mechanism for homeostatic CNS regulatory systems to mount extended responses in order, for example, to restore blood volume following hemorrhage or for sustained arousal.
这个项目两年的支持将使我们能够执行原始申请的目标3和目标4中提出的实验。在美国心脏协会的支持下,我们已经完成了目标1和目标2的大部分。这支持了我们的假设,即视上神经元(SON)同时暴露于ATP和苯肾上腺素诱导向非脱敏的嗜离子嘌呤能受体亚型转变,使ATP维持抗利尿激素(VP)释放数小时。这项工作已提交出版。美国心脏协会的资助不支持Aims 3和4,这对理解去甲肾上腺素诱导嘌呤能受体亚型转变的机制至关重要:Aims 3的重点是鉴定SON中由苯肾上腺素激活的1-肾上腺素能受体亚型,Aim 4将鉴定SON中由苯肾上腺素激活的信号级联。确定1-R信号级联对于理解为什么ATP激活代谢嘌呤能受体不会诱导与苯肾上腺素相同的效果至关重要。苯肾上腺素诱导对ATP的持续反应的能力很重要,因为它提供了一种机制,使体内平衡的中枢神经系统调节系统能够产生延长的反应,例如,在出血后恢复血容量或持续唤醒。
项目成果
期刊论文数量(38)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Estrogen receptor-alpha expression in osmosensitive elements of the lamina terminalis: regulation by hypertonicity.
终板渗透敏感元件中雌激素受体α的表达:高渗调节。
- DOI:10.1152/ajpregu.00136.2004
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Somponpun,SuwitJ;Johnson,AlanKim;Beltz,Terry;Sladek,CeliaD
- 通讯作者:Sladek,CeliaD
Dehydration induces Fos, but not increased vasopressin mRNA in the supraoptic nucleus of aged rats.
脱水会诱导老年大鼠视上核中的 Fos,但不会增加加压素 mRNA。
- DOI:10.1016/0006-8993(94)90229-1
- 发表时间:1994
- 期刊:
- 影响因子:2.9
- 作者:Sladek,CD;Olschowka,JA
- 通讯作者:Olschowka,JA
ATP increases intracellular calcium in supraoptic neurons by activation of both P2X and P2Y purinergic receptors.
ATP 通过激活 P2X 和 P2Y 嘌呤受体来增加视上神经元的细胞内钙。
- DOI:10.1152/ajpregu.00495.2006
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Song,Zhilin;Vijayaraghavan,Sukumar;Sladek,CeliaD
- 通讯作者:Sladek,CeliaD
Osmotic regulation of estrogen receptor-beta expression in magnocellular vasopressin neurons requires lamina terminalis.
大细胞加压素神经元中雌激素受体β表达的渗透调节需要终板。
- DOI:10.1152/ajpregu.00478.2003
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Somponpun,SuwitJ;Johnson,AlanKim;Beltz,Terry;Sladek,CeliaD
- 通讯作者:Sladek,CeliaD
Integration of thermal and osmotic regulation of water homeostasis: the role of TRPV channels.
- DOI:10.1152/ajpregu.00270.2013
- 发表时间:2013-10
- 期刊:
- 影响因子:0
- 作者:C. Sladek;A. Johnson
- 通讯作者:C. Sladek;A. Johnson
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CELIA D SLADEK其他文献
CELIA D SLADEK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CELIA D SLADEK', 18)}}的其他基金
Oxytocin responses to insulin and glucose: Impact of lactation and obesity
催产素对胰岛素和葡萄糖的反应:哺乳和肥胖的影响
- 批准号:
8243875 - 财政年份:2012
- 资助金额:
$ 37.37万 - 项目类别:
Oxytocin responses to insulin and glucose: Impact of lactation and obesity
催产素对胰岛素和葡萄糖的反应:哺乳和肥胖的影响
- 批准号:
8431741 - 财政年份:2012
- 资助金额:
$ 37.37万 - 项目类别:
Neurokinin 3 Receptor: Nuclear Localization in Supraoptic Neurons
神经激肽 3 受体:视上神经元的核定位
- 批准号:
7471320 - 财政年份:2008
- 资助金额:
$ 37.37万 - 项目类别:
Neuropeptide Regulation Vasopressin/Oxytocin Secretion
神经肽调节加压素/催产素分泌
- 批准号:
6845349 - 财政年份:2002
- 资助金额:
$ 37.37万 - 项目类别:
Neuropeptide Regulation Vasopressin/Oxytocin Secretion
神经肽调节加压素/催产素分泌
- 批准号:
7047737 - 财政年份:2002
- 资助金额:
$ 37.37万 - 项目类别:
Neuropeptide Regulation Vasopressin/Oxytocin Secretion
神经肽调节加压素/催产素分泌
- 批准号:
6556138 - 财政年份:2002
- 资助金额:
$ 37.37万 - 项目类别:
Neuropeptide Regulation Vasopressin/Oxytocin Secretion
神经肽调节加压素/催产素分泌
- 批准号:
6640699 - 财政年份:2002
- 资助金额:
$ 37.37万 - 项目类别:
Neuropeptide Regulation Vasopressin/Oxytocin Secretion
神经肽调节加压素/催产素分泌
- 批准号:
6710592 - 财政年份:2002
- 资助金额:
$ 37.37万 - 项目类别:
PILOT PROJECT--GENE REGULATION IN VASOPRESSIN NEURONS DURING AGING
试点项目——衰老过程中加压素神经元的基因调控
- 批准号:
6098263 - 财政年份:1996
- 资助金额:
$ 37.37万 - 项目类别:
相似国自然基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
- 批准号:82074359
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
- 批准号:81570244
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
- 批准号:81171113
- 批准年份:2011
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Targeting the A2B Adenosine Receptor for Immunoprevention of Pancreatic Cancer
靶向 A2B 腺苷受体用于胰腺癌的免疫预防
- 批准号:
10929664 - 财政年份:2023
- 资助金额:
$ 37.37万 - 项目类别:
Exploring the role of adenosine A2A receptors in Schizophrenia using opto-pharmacologically controlled allosteric modulation.
利用光药理学控制的变构调节探索腺苷 A2A 受体在精神分裂症中的作用。
- 批准号:
23K14685 - 财政年份:2023
- 资助金额:
$ 37.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Role of Adenosine Kinase in Mixed Diastolic Heart Failure and Alzheimer Disease
腺苷激酶在混合性舒张性心力衰竭和阿尔茨海默病中的作用
- 批准号:
10679989 - 财政年份:2023
- 资助金额:
$ 37.37万 - 项目类别:
Allostery-driven G protein selectivity in the adenosine A1 receptor
腺苷 A1 受体中变构驱动的 G 蛋白选择性
- 批准号:
BB/W016974/1 - 财政年份:2023
- 资助金额:
$ 37.37万 - 项目类别:
Research Grant
Investigation of new test methods for adenosine-sensitive atrioventricular block
腺苷敏感型房室传导阻滞新检测方法的探讨
- 批准号:
23K07566 - 财政年份:2023
- 资助金额:
$ 37.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing the role of adenosine pathway in SIV pathogenesis
探讨腺苷途径在 SIV 发病机制中的作用
- 批准号:
10760676 - 财政年份:2023
- 资助金额:
$ 37.37万 - 项目类别:
The role of A1 adenosine receptor signaling in the decline of S. pneumoniae killing by neutrophils in vaccinated aged hosts
A1 腺苷受体信号传导在疫苗接种老年宿主中中性粒细胞杀伤肺炎链球菌下降中的作用
- 批准号:
10605737 - 财政年份:2023
- 资助金额:
$ 37.37万 - 项目类别:
Adenosine triphosphate as a master variable for biomass in the oceanographic context
三磷酸腺苷作为海洋学背景下生物量的主变量
- 批准号:
2319114 - 财政年份:2023
- 资助金额:
$ 37.37万 - 项目类别:
Standard Grant
Late-Stage Functionalisation of Cyclic Guanosine Monophosphate - Adenosine Monophosphate
环单磷酸鸟苷-单磷酸腺苷的后期功能化
- 批准号:
2751533 - 财政年份:2022
- 资助金额:
$ 37.37万 - 项目类别:
Studentship
Postnatal development of adenosine kinase in the brainstem network that controls breathing
控制呼吸的脑干网络中腺苷激酶的出生后发育
- 批准号:
573323-2022 - 财政年份:2022
- 资助金额:
$ 37.37万 - 项目类别:
University Undergraduate Student Research Awards